Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core

Detalles Bibliográficos
Autores principales: Grimm, Juliane, Bhayadia, Raj, Gack, Lucie, Heckl, Dirk, Klusmann, Jan-Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252908/
https://www.ncbi.nlm.nih.gov/pubmed/35610347
http://dx.doi.org/10.1038/s41375-022-01603-3
_version_ 1784740379039367168
author Grimm, Juliane
Bhayadia, Raj
Gack, Lucie
Heckl, Dirk
Klusmann, Jan-Henning
author_facet Grimm, Juliane
Bhayadia, Raj
Gack, Lucie
Heckl, Dirk
Klusmann, Jan-Henning
author_sort Grimm, Juliane
collection PubMed
description
format Online
Article
Text
id pubmed-9252908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92529082022-07-06 Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core Grimm, Juliane Bhayadia, Raj Gack, Lucie Heckl, Dirk Klusmann, Jan-Henning Leukemia Letter Nature Publishing Group UK 2022-05-24 2022 /pmc/articles/PMC9252908/ /pubmed/35610347 http://dx.doi.org/10.1038/s41375-022-01603-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Grimm, Juliane
Bhayadia, Raj
Gack, Lucie
Heckl, Dirk
Klusmann, Jan-Henning
Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
title Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
title_full Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
title_fullStr Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
title_full_unstemmed Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
title_short Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
title_sort combining lsd1 and jak-stat inhibition targets down syndrome-associated myeloid leukemia at its core
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252908/
https://www.ncbi.nlm.nih.gov/pubmed/35610347
http://dx.doi.org/10.1038/s41375-022-01603-3
work_keys_str_mv AT grimmjuliane combininglsd1andjakstatinhibitiontargetsdownsyndromeassociatedmyeloidleukemiaatitscore
AT bhayadiaraj combininglsd1andjakstatinhibitiontargetsdownsyndromeassociatedmyeloidleukemiaatitscore
AT gacklucie combininglsd1andjakstatinhibitiontargetsdownsyndromeassociatedmyeloidleukemiaatitscore
AT heckldirk combininglsd1andjakstatinhibitiontargetsdownsyndromeassociatedmyeloidleukemiaatitscore
AT klusmannjanhenning combininglsd1andjakstatinhibitiontargetsdownsyndromeassociatedmyeloidleukemiaatitscore

Ejemplares similares